pA2 online
© Copyright 2004 The British Pharmacological Society

123P University of Bath
Summer Meeting July 2004

Potassium channel activity in lymphocytes of patients with fibromyalgia (FMS)

Elisabeth Shawcross1, Mourad Labib2, Jon H Raphael3 & Kim Lawson1, 1Biomedical Research Centre, Sheffield Hallam University, Sheffield, S1 1WB; 2Dept of Clinical Biochemistry, Russells Hall Hospital, Dudley, DY1 2HQ; 3Dept of Pain Management, Guest Hospital, Dudley, DY1 4SE

Print abstract

Search PubMed for:


Shawcross E
Labib M
Raphael JH
Lawson K

A reduced functioning of lymphocytes has been reported in a number of pain conditions, such as migraine, cluster headaches and FMS (Galeotti et al., 2001). Potassium (K+) channels play a critical role in the functioning and proliferation of lymphocytes. The aim of this study was to investigate, using a Rb+ efflux assay, the activity of the K+channels in lymphocytes of patients with FMS.

Lymphocytes were isolated from blood, from patients with FMS (n=5) or healthy volunteers (control, n=14), using density-gradient centrifugation. A non-radioactive rubidium efflux assay was used to functionally analyse K+channel activity (Terstappen, 1999). The isolated lymphocytes were incubated in 2ml Rb+-PSS (Rb+ containing physiological salt solution mM: NaCl 118, RbCl 5.8, CaCl2 2.5, MgSO4 1.2, glucose 11, NaHCO3 25, NaH2PO4 1.2) for 18 hrs at 37°C. The cells were washed and resuspended in K+-PSS (mM: NaCl 0-118, KCl 4.6-120, CaCl2 2.5, MgSO4 1.2, glucose 11, NaHCO3 25, KH2PO4 1.2) as six aliquots. When the [KCl] was increased above 4.6mM the [NaCl] was decreased from 118mM.K+channel modulators were included in the K+-PSS. After 10 min incubation the supernatant was removed and collected. Cell lysates were collected by the addition of 2ml Triton X-100 (1%). Rb+ content of the supernatant and cell lysate were determined by flame atomic absorption spectroscopy and Rb+ efflux (%) was calculated. Data is presented as mean values (±s.e.m.).

Increasing the [KCl] in the supernatant augmented the Rb+ efflux (%) with responses in lymphocytes from control and FMS samples not being significantly different (Table 1).

Table 1. Rb+ efflux (%) in response to increasing extracellular [KCl].

[KCl](mM)

4.6

60

80

100

120

Control (n=14)

22.9±2.5

47.5±1.8

56.5±2.3

58.2±2.8

63.0±2.6

FMS (n=5)

16.9±4.4

44.9±4.4

54.4±2.2

53.9±3.4

54.9±6.0

The Rb+ efflux (%) from lymphocytes of FMS patients was different from that of control subjects following exposure to margatoxin (MgTx 10nM) or margatoxin (MgTx 10nM) plus charybdotoxin (ChTx 100nM) when incubated with K+ PSS containing 4.6 or 80mM KCl (Table 2). Data for 80mM KCl were corrected for baseline variations by subtraction of the value obtained with 4.6mM KCl.

Table 2. Effects of K+channel blockers on Rb+ efflux (%).

[KCl](mM)

4.6

80 (corrected for baseline)

(n)

Vehicle

MgTx

MgTx+ChTx

Vehicle

MgTx

MgTx+ChTx

Control (14)

22.9±2.5

28.3±3.9

26.3±2.0

33.5±2.9

26.3±2.4

26.1±1.7

FMS (5)

16.9±4.4

13.3±1.7b

13.6±2.8b

37.5±4.8

35.8±4.5a

37.0±4.6a

aP<0.1, bP<0.05 Control vs. FMS (Student’s Unpaired T-test)

In conclusion, although the lymphocytes from FMS patients and healthy volunteers responded similarly to KCl stimulation, responses in the presence of the K+channel blockers margatoxin and charybdotoxin differed. These findings support the suggestion that altered K+channel function may be associated with FMS (Lawson, 2001).

Galeotti N et al. (2001) Cephalagia 21: 38-45
Lawson K (2001) Myalgies Intl 2: 25-30
Terstappen GC (1999) Anal Biochem 272: 149-155